what does bpc 157 Peptide BPC-157 The Hidden Risks of BPC‑157:

introducing how obesity and insulin resistance (initiating factors for the onset of MetS and diabetes) may be opposed by recombinant-human-IGF-1 (rhIGF-1) treatment

There is no reliable timeline, because the human data does not exist

(jofem.org) But it is not in the same efficacy universe as GLP-1/GIP medications for weight loss, and it should not be positioned that way

[DOI] [PubMed] [Google Scholar] 190.Rogers J, Smith J, Starmer GA, Whitfield JB

Anecdotal reports from researchers and clinicians using it for investigational purposes only further bolster this hypothesis, with many observing significant improvements in pain and function